Scientists have developed several analogs of GLP-1, with the two most notable ones being semaglutide and liraglutide, which share 94-97% homology with the active form of the GLP-1 hormone [8, 9]
Study Limitations and Future Research Directions The interpretation of the findings is limited by the small GLP-1RA cohort (n = 12), baseline imbalances in BMI and sex, the single-center retrospective design, incomplete autoantibody testing, and a median follow-up of approximately eight months
22 This highlights the importance of continuous pharmacist involvement to assess tolerability, determine when dose adjustments or therapy changes are warranted, and guide patients through individualized management strategies
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
A reaction to calorie restriction has been experimentally shown to affect lifespan in animals [40, 41] and humans [42, 43]
Key points Available as a twice-daily or weekly injection Used less often today due to newer options with better convenience Oral GLP-1 Medicines: A New Direction One of the biggest challenges with GLP-1 therapy has been injections